Formal Issuance of a U.S. Patent Strengthens Drug Development Business and Provides Valuable Intellectual Property to Address Large Unmet Market Opportunity SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- ...
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of ...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Apr 25, 2016) - RepliCel Life Sciences Inc. (REPCF)(TSX VENTURE:RP)(P6P1.F), a clinical stage regenerative medicine company focused on the development of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果